Literature DB >> 8225674

An audit of emergency echocardiography in a district general hospital.

M O Balogun1, A B Omotoso, E Bell, G Y Lip, J D Gemmill, K J Hogg, F G Dunn.   

Abstract

Eighty patients (43 M, 37 F), aged 23-89 years who were referred for emergency echocardiography over a 12-month period were prospectively studied in order to determine the reasons for emergency echocardiography and the influence of its results on patient management. The most frequent emergency request was to clarify whether the basis for cardiomegaly in a haemodynamically unstable patient was pericardial effusion or left ventricular dilatation. Other reasons for requests were for assessment for source of systemic emboli, acute complications of myocardial infarction, endocarditis, valve dysfunction and cardiac trauma. As a consequence of the emergency echocardiography, management was immediately influenced in 19 patients. This study has provided information on the specific settings in which emergency echocardiography can be justified.

Entities:  

Mesh:

Year:  1993        PMID: 8225674     DOI: 10.1016/0167-5273(93)90137-6

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  2 in total

1.  Two-dimensional and Doppler echocardiographic evaluation of patients presenting at Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria: a prospective study of 2501 subjects.

Authors:  Rasaaq Ayodele Adebayo; Patience Olayinka Akinwusi; Michael Olabode Balogun; Anthony Olubunmi Akintomide; Victor Oladeji Adeyeye; Olugbenga Olusola Abiodun; Luqman Adeleke Bisiriyu; Suraj Adefabi Ogunyemi; Ebenezer Adekunle Ajayi; Olufemi Eyitayo Ajayi; Adebayo Tolulope Oyedeji
Journal:  Int J Gen Med       Date:  2013-07-03

2.  Relationship between clinically assessed heart failure severity and the Tei index in Nigerian patients.

Authors:  Olarinde Jeffrey Ogunmola; Anthony Olubunmi Akintomide; Adeyemi Michael Olamoyegun
Journal:  BMC Res Notes       Date:  2013-11-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.